Does dexamethasone implant combination with aflibercept monotherapy affect one-year outcomes in treatment-naive diabetic macular edema with inflammatory biomarkers?

International ophthalmology, 2024-02, Vol.44 (1), p.51-51 [Peer Reviewed Journal]

The Author(s), under exclusive licence to Springer Nature B.V. 2024. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. ;2024. The Author(s), under exclusive licence to Springer Nature B.V. ;ISSN: 0165-5701 ;EISSN: 1573-2630 ;DOI: 10.1007/s10792-024-02963-8 ;PMID: 38336941

Digital Resources/Online E-Resources